MenQuadfi Unia Europejska - islandzki - EMA (European Medicines Agency)

menquadfi

sanofi pasteur - neisseria meningitidis group c polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group a polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group y polysaccharide conjugated to tetanus toxoid, neisseria meningitidis group w-135 polysaccharide conjugated to tetanus toxoid - meningitis, meningococcal - bóluefni - menquadfi is indicated for active immunisation of individuals from the age of 12 months and older against invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w, and y. the use of this vaccine should be in accordance with available official recommendations.

NeisVac-C Stungulyf, dreifa Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

neisvac-c stungulyf, dreifa

pfizer aps - neisseria meningitidis c (oligosakkaríð eða polýsakkaríð) - stungulyf, dreifa

Varivax Stungulyfsstofn og leysir, dreifa Islandia - islandzki - LYFJASTOFNUN (Icelandic Medicines Agency)

varivax stungulyfsstofn og leysir, dreifa

merck sharp & dohme b.v.* - varicella virus oka/merck strain, (live, attenuated) produced in human diploid (mrc-5) cells - stungulyfsstofn og leysir, dreifa